Company Filing History:
1 out of 207 
1 out of 47 Years Active: 1989-1999
Title: The Innovations of Robert Charles Rees
Introduction
Robert Charles Rees is a notable inventor based in Sheffield, GB. He has made significant contributions to the field of pharmaceuticals, particularly in immunomodulation and cancer treatment. With a total of 2 patents, his work has had a meaningful impact on medical science.
Latest Patents
Among his latest patents is the development of insulin-like growth factor II as an antitumor agent. Additionally, he has created an immunomodulating pharmaceutical composition that includes an effective amount of NS1, which induces leukocyte interferon production. This innovative method aims to modulate the immune response in humans and other animals by administering NS1 to stimulate leukocyte IFN production.
Career Highlights
Throughout his career, Robert has worked with prominent companies such as SmithKline Beecham Corporation and Pharmacia & Upjohn. His experience in these organizations has allowed him to refine his expertise in pharmaceutical development and innovation.
Collaborations
Robert has collaborated with esteemed colleagues, including Barbara J Dalton and Paul Schofield. Their joint efforts have contributed to advancements in their respective fields.
Conclusion
Robert Charles Rees is a distinguished inventor whose work in immunomodulation and cancer treatment continues to influence the pharmaceutical industry. His patents and collaborations reflect his commitment to advancing medical science.